Cargando…

Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments

This article reviews therapeutic drug monitoring (TDM) use for current inflammatory bowel disease (IBD) treatments. IBD comprises Crohn’s disease and ulcerative colitis-chronic gastrointestinal inflammatory disorders. Treatment options for moderate to severe IBD include thiopurines; methotrexate; bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Scott D., Shivashankar, Raina, Quirk, Daniel, Zhang, Haiying, Telliez, Jean-Baptiste, Andrews, John, Marren, Amy, Mukherjee, Arnab, Loftus, Edward V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Clinical Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960149/ https://www.ncbi.nlm.nih.gov/pubmed/32740098 http://dx.doi.org/10.1097/MCG.0000000000001396

Ejemplares similares

Immunogenicity of biologics in inflammatory bowel disease
por: Vermeire, Séverine, et al.
Publicado: (2018)

Novel and Emerging Therapies for Inflammatory Bowel Disease
por: Al-Bawardy, Badr, et al.
Publicado: (2021)

Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases
por: Park, Sang Hyoung, et al.
Publicado: (2020)

Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease: current data and future directions
por: Ward, Mark G., et al.
Publicado: (2018)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Therapeutic drug monitoring in inflammatory bowel disease treatments
por: Wang, Meng-Yao, et al.
Publicado: (2022)

Updates in therapeutic drug monitoring in inflammatory bowel disease
por: Lodhia, Nilesh, et al.
Publicado: (2022)

Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring
por: Albader, Farah, et al.
Publicado: (2021)

The microbiota in inflammatory bowel disease: current and therapeutic insights
por: Lane, Erin R, et al.
Publicado: (2017)

Multi-utility of therapeutic drug monitoring in inflammatory bowel diseases
por: Martins, Camilla de Almeida, et al.
Publicado: (2022)

Therapeutic drug monitoring for biological medications in inflammatory bowel disease
por: Cogan, Rachel C., et al.
Publicado: (2022)

Economic Burden of Fatigue in Inflammatory Bowel Disease
por: Ananthakrishnan, Ashwin N, et al.
Publicado: (2023)

The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries
por: Aniwan, Satimai, et al.
Publicado: (2022)

Editorial: JAK inhibition in autoimmune and inflammatory diseases
por: Telliez, Jean-Baptiste, et al.
Publicado: (2022)

Obesity in inflammatory bowel disease: A review of its role in the pathogenesis, natural history, and treatment of IBD
por: Johnson, Amanda M., et al.
Publicado: (2021)

Monitoring inflammatory bowel disease during pregnancy: Current literature and future challenges
por: Choden, Tenzin, et al.
Publicado: (2018)

The Clinical Characteristics and Treatment Outcomes of Concomitant Eosinophilic Esophagitis and Inflammatory Bowel Disease
por: Urquhart, Siri A, et al.
Publicado: (2021)

Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease
por: Simsek, Melek, et al.
Publicado: (2017)

Advances in Therapeutic Drug Monitoring in Biologic Therapies for Pediatric Inflammatory Bowel Disease
por: Kapoor, Akshay, et al.
Publicado: (2021)

Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease
por: Kato, Masaichi, et al.
Publicado: (2021)

Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right place
por: Truta, Brindusa
Publicado: (2022)

Novel risk factors and outcomes in inflammatory bowel disease patients with Clostridioides difficile infection
por: Voth, Elida, et al.
Publicado: (2021)

Drug therapy and monitoring for inflammatory bowel disease: a multinational questionnaire investigation in Asia
por: Cai, Chenwen, et al.
Publicado: (2022)

Tofacitinib is not a biologic
por: Marren, Amy S.
Publicado: (2017)

Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease
por: Restellini, Sophie, et al.
Publicado: (2021)

A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
por: Vaughn, Byron P.
Publicado: (2021)

Urinary Metabolites Enable Differential Diagnosis and Therapeutic Monitoring of Pediatric Inflammatory Bowel Disease
por: Yamamoto, Mai, et al.
Publicado: (2021)

Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease
por: Kolho, Kaija-Leena
Publicado: (2021)

Potential Role of Methotrexate Polyglutamates in Therapeutic Drug Monitoring for Pediatric Inflammatory Bowel Disease
por: Morrow, Ryan, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Biologics for Patients with Inflammatory Bowel Diseases: How, When, and for Whom?
por: Wu, Jia-Feng
Publicado: (2022)

Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel Disease
por: Nakase, Hiroshi
Publicado: (2020)

Linking Inflammatory Bowel Disease Symptoms to Changes in the Gut Microbiome Structure and Function
por: Hassouneh, Sayf Al-Deen, et al.
Publicado: (2021)

Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
por: Eun, Chang Soo
Publicado: (2017)

Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond
por: Di Paolo, Antonello, et al.
Publicado: (2021)

Timely Monitoring of Inflammation by Fecal Lactoferrin Rapidly Predicts Therapeutic Response in Inflammatory Bowel Disease
por: Sorrentino, Dario, et al.
Publicado: (2021)

A Review of Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Receiving Combination Therapy
por: Patel, Sanket, et al.
Publicado: (2023)

Examining the influence of inflammatory bowel disease medications on sleep quality
por: Barnes, Alex, et al.
Publicado: (2023)

Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010
por: Aniwan, Satimai, et al.
Publicado: (2019)

Cytomegalovirus and the Seemingly Immunocompetent Host: A Case of a Perforating Gastric Ulcer
por: Krajicek, Edward, et al.
Publicado: (2017)

Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
por: Cui, Guanglin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s62h94pk822pecr7ov8dmr4lkn